IE782540L - Tablets containing¹1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane - Google Patents
Tablets containing¹1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropaneInfo
- Publication number
- IE782540L IE782540L IE782540A IE254078A IE782540L IE 782540 L IE782540 L IE 782540L IE 782540 A IE782540 A IE 782540A IE 254078 A IE254078 A IE 254078A IE 782540 L IE782540 L IE 782540L
- Authority
- IE
- Ireland
- Prior art keywords
- carboxychromon
- hydroxypropane
- yloxy
- tablets
- bis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The tablet is designed to be swallowed and to disintegrate in the presence of the gastrointestinal fluids. It comprises 5 to 80 % by weight of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane or one of its pharmaceutically acceptable salts and 20 to 95 % by weight of a mixture of an alkali metal carbonate or bicarbonate or alkaline earth metal carbonate or bicarbonate and citric acid. The tablet has an equilibrium relative moisture content of less than 25 %. These tablets are suitable for the treatment of gastrointestinal disorders.
[GB1595220A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB53825/77A GB1595220A (en) | 1977-12-23 | 1977-12-23 | Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE782540L true IE782540L (en) | 1979-06-23 |
| IE47539B1 IE47539B1 (en) | 1984-04-18 |
Family
ID=10469110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2540/78A IE47539B1 (en) | 1977-12-23 | 1978-12-21 | Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5489016A (en) |
| AU (1) | AU523616B2 (en) |
| BE (1) | BE872918A (en) |
| CA (1) | CA1108992A (en) |
| CH (1) | CH641349A5 (en) |
| DE (1) | DE2855001A1 (en) |
| DK (1) | DK568278A (en) |
| FI (1) | FI783897A (en) |
| FR (1) | FR2412310A1 (en) |
| GB (1) | GB1595220A (en) |
| IE (1) | IE47539B1 (en) |
| IL (1) | IL56239A (en) |
| IT (1) | IT7831068A0 (en) |
| LU (1) | LU80721A1 (en) |
| NL (1) | NL7812344A (en) |
| NZ (1) | NZ189255A (en) |
| SE (1) | SE7813062L (en) |
| ZA (1) | ZA787155B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07116017B2 (en) * | 1986-05-17 | 1995-12-13 | アース製薬株式会社 | Bath additive |
| GB9824604D0 (en) * | 1998-11-11 | 1999-01-06 | Hewlett Healthcare Limited | Treatment of allergic conditions |
| JP2004514732A (en) * | 2000-12-06 | 2004-05-20 | ファルマシア・コーポレーション | Rapidly dispersing pharmaceutical composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2132521A1 (en) * | 1971-04-06 | 1972-11-24 | Sofrader Sa | Effervescent tablets prdn - by controlled drying in effervescent granule formation |
| GB1423985A (en) * | 1972-02-15 | 1976-02-04 | Fisons Ltd | Pharmaceutical compositions containing bischromonyloxy compounds |
| GB1517153A (en) * | 1974-11-30 | 1978-07-12 | Fisons Ltd | Naphthopyran-and benzodipyran-2-carboxylic acids and derivatives thereof |
| GB1570993A (en) * | 1976-05-21 | 1980-07-09 | Fisons Ltd | Pharmaceutical tablet formulation |
| GB1557082A (en) * | 1977-01-25 | 1979-12-05 | Fisons Ltd | Pharmaceutical mixture containing an antiinflammatory |
-
1977
- 1977-12-23 GB GB53825/77A patent/GB1595220A/en not_active Expired
-
1978
- 1978-12-18 IL IL56239A patent/IL56239A/en unknown
- 1978-12-18 DK DK568278A patent/DK568278A/en not_active Application Discontinuation
- 1978-12-18 AU AU42654/78A patent/AU523616B2/en not_active Expired
- 1978-12-19 SE SE7813062A patent/SE7813062L/en unknown
- 1978-12-19 FI FI783897A patent/FI783897A/en unknown
- 1978-12-19 CH CH1290478A patent/CH641349A5/en not_active IP Right Cessation
- 1978-12-20 DE DE19782855001 patent/DE2855001A1/en not_active Withdrawn
- 1978-12-20 BE BE192444A patent/BE872918A/en not_active IP Right Cessation
- 1978-12-20 NZ NZ189255A patent/NZ189255A/en unknown
- 1978-12-20 ZA ZA00787155A patent/ZA787155B/en unknown
- 1978-12-20 NL NL7812344A patent/NL7812344A/en not_active Application Discontinuation
- 1978-12-20 IT IT7831068A patent/IT7831068A0/en unknown
- 1978-12-21 IE IE2540/78A patent/IE47539B1/en unknown
- 1978-12-21 JP JP15697478A patent/JPS5489016A/en active Pending
- 1978-12-21 CA CA318,406A patent/CA1108992A/en not_active Expired
- 1978-12-22 FR FR7836221A patent/FR2412310A1/en active Granted
- 1978-12-22 LU LU80721A patent/LU80721A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7812344A (en) | 1979-06-26 |
| IE47539B1 (en) | 1984-04-18 |
| CA1108992A (en) | 1981-09-15 |
| SE7813062L (en) | 1979-06-24 |
| FR2412310B1 (en) | 1982-12-31 |
| IT7831068A0 (en) | 1978-12-20 |
| IL56239A (en) | 1983-02-23 |
| BE872918A (en) | 1979-06-20 |
| AU4265478A (en) | 1979-06-28 |
| NZ189255A (en) | 1984-05-31 |
| JPS5489016A (en) | 1979-07-14 |
| IL56239A0 (en) | 1979-03-12 |
| AU523616B2 (en) | 1982-08-05 |
| CH641349A5 (en) | 1984-02-29 |
| LU80721A1 (en) | 1979-09-07 |
| FI783897A (en) | 1979-06-24 |
| FR2412310A1 (en) | 1979-07-20 |
| ZA787155B (en) | 1979-12-27 |
| GB1595220A (en) | 1981-08-12 |
| DK568278A (en) | 1979-06-24 |
| DE2855001A1 (en) | 1979-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES430431A1 (en) | Direct compression tabletting composition and pharmaceutical tablets produced therefrom | |
| EP0306454A3 (en) | Tablets having improved bioadhesion to mucous membranes | |
| KR910000100A (en) | Ranitidine-containing pharmaceutical composition | |
| MD872G2 (en) | Pharmaceutical effrvescent composition and preparation on the basis of it, method for preparation preparing | |
| DE2963990D1 (en) | Analgesic tablet and process for its preparation | |
| JPS5420126A (en) | Pharmaceutical composition | |
| JPS52128210A (en) | Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives | |
| CA2050970A1 (en) | Pharmaceutical compositions containing furan derivatives | |
| IE34811B1 (en) | Effervescent tablets and powders | |
| IE782540L (en) | Tablets containing¹1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane | |
| JPS5350316A (en) | Drug composition for oral administration | |
| JPS5661311A (en) | Thial amide or prolonged pharmaceutical preparation comprising its salt | |
| JPS6440423A (en) | Patch for mucosa in oral cavity | |
| GB1381426A (en) | Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents | |
| GB1327560A (en) | Effervescent pharmaceutical preparations | |
| JPS52130905A (en) | Medicinal composition | |
| JPS53127432A (en) | Novel physiologically active substance, anthglutin, and its preparation | |
| IL55895A0 (en) | Vinylcyclopropanecarboxylic acid 3-phenoxy- -vinylbenzyl esters, their production and their use in combating pests | |
| JPS5344617A (en) | Drug composition | |
| JPS53148598A (en) | Improvement of smoking taste of tobacco | |
| JPS5251362A (en) | Preparation of optically active pyrrolidine derivatives | |
| NZ226696A (en) | Tablet composition comprising a phthalazine acetic acid derivative as the active ingredient present in from 83-88 wt% | |
| JPS53136520A (en) | Rapidly disintegratable tablet for fungicide | |
| JPS5310896A (en) | Cdse humidity sensitive material and its manufacturing process | |
| JPS53108983A (en) | Preparation of 5-fluorouracil |